前列腺癌查:是时候采取新的方法了吗? 一篇文章的复习文章
Christopher James Mikulas1, Kabeer Ali1, Nirmal Onteddu1
1University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USA.
概括
使用PSA和DRE进行前列腺癌查可以提高生存率,但对临床显著的前列腺癌 (CSPC) 的准确性较低. 目前正在进行研究,以加强早期检测并减少不必要的程序.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 由于前列腺特异抗原 (PSA) 和数字直肠检查 (DRE) 等传统方法的局限性,前列腺癌查面临挑战.
- 这些方法对临床显著的前列腺癌 (CSPC) 具有较低的积极预测值,导致不必要的活检和潜在的并发症.
研究的目的:
- 为了解决目前前列腺癌查工具的局限性.
- 探索新的方法和对现有试验的二次分析,以改善临床上显著的前列腺癌的检测.
主要方法:
- 来自前列腺,肺,结肠直肠和卵巢癌查试验的数据的二次分析.
- 调查前列腺特异性抗原 (PSA) 水平与临床显著前列腺癌 (CSPC) 的存在之间的关联.
- 评估新的诊断工具,如IP1-PROSTAGRAM Tri. 这样的.
主要成果:
- 传统的查测试 (PSA,DRE) 对前列腺癌特异性死亡率产生重大影响.
- 然而,这些测试对于识别临床上显著的前列腺癌 (CSPC) 具有较差的积极预测价值.
- 目前正在进行的研究旨在完善查准确性并最大限度地减少假阳性.
结论:
- 优化前列腺癌查仍然是一个关键的临床挑战.
- 对像PLCO这样的试验进行进一步的研究和分析对于提高查测试的特异性至关重要.
- 需要新的诊断策略来减少不必要的活检和相关并发症.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...